Paper
Revolutionary advances in 2-methacryloyloxyethyl phosphorylcholine polymers as biomaterials.
Published May 1, 2019 · K. Ishihara
Journal of biomedical materials research. Part A
155
Citations
3
Influential Citations
Abstract
In the last 40 years, many strategies to fabricate biocompatible and antithrombogenic polymers have been proposed, especially in Japan. The development of one such polymers composed of 2-methacryloyloxyethyl phosphorylcholine unit, is described in this review, with specific examples of use in biomedical devices. These polymers are typically incorporated into other materials to effectively prevent unfavorable biological responses and reactions. For example, the polymers suppress protein adsorption and cell adhesion to materials in contact with plasma or whole blood, even in the absence of anticoagulant. These properties are due to the extreme hydrophilicity and electrically neutral nature of the polymers, as well as to the ability of phosphorylcholine to induce bulk-like behavior in surrounding waters. Accordingly, these polymers have been used worldwide to modify the surfaces and improve the overall biocompatibility of such medical devices as long-term implantable artificial organs. © 2019 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 107A: 933-943, 2019.
Highly Cited2-methacryloyloxyethyl phosphorylcholine polymers effectively prevent unfavorable biological responses and reactions, improving biocompatibility in medical devices like long-term implantable artificial organs.
Sign up to use Study Snapshot
Consensus is limited without an account. Create an account or sign in to get more searches and use the Study Snapshot.
Full text analysis coming soon...